Biotechs: Rocket Stocks from the Lab:
Biotech stocks like Amgen have performed strongly since 2008, with innovations in medicine and acquisitions that have ...
deraktionaer.de/artikel/deraktionaermagazin/biotechs-kursraketen-aus-dem-labor-20397437.html
Story Details
| Last Updated | |
| Total Articles | 1 |
Main Topics
facility that provides controlled conditions in which scientific or technological research, experiments, and measurement may be performed
Similar to This
Previous
OpinionBiotechs buck a sluggish IPO market, but investors should tread warily: While a number of IPOs have been pulled or delayed in 2026, the biotech sector has bucked ...
cnbc.com/2026/10/28/biotech-ipo-market-investor-risks.html
Paid articlePaywall After Bitcoin and Nvidia: With contrarian instinct to new stock market rockets: Invest contrarian: Secure your Hot Stock Report now with a 10% discount (Code: ...
deraktionaer.de/artikel/aktien/nach-bitcoin-und-nvidia-mit-antizyklischem-instinkt-zu-neuen-kursraketen-20417513.html
AI in Drug Discovery: What Pharmaceutical Companies Are Buying from Small AI Biotechs - | Golem.de
golem.de/news/ki-in-der-wirkstoffforschung-was-pharmakonzerne-bei-kleinen-ki-biotechs-einkaufen-2610-213546.html
Barron's Sep 14
Big Pharma Is Pouring Billions Into China’s Biotechs: Big Pharma firms have cut license deals worth tens of billions of dollars for cancer drugs invented in ...
barrons.com/articles/pharma-china-biotech-britol-meyers-eli-lilly-67c4828f
Paid articlePaywall
STAT Jul 28
From ‘lost cause’ to gold rush: Biotechs swarm to cure AATD : Biotech companies race to cure alpha-1 antitrypsin deficiency, AATD, fueling patent disputes ...
statnews.com/2026/07/28/biotech-industry-race-aatd-cure-gene-editing-alpha-1-antitrypsin-deficiency/
U.S. Biotechs Are Keeping More Secrets to Beat Copycats in China: Western biotechs get new playbook with tighter controls to stay ahead of ultraefficient ...
wsj.com/tech/biotech/u-s-biotechs-are-keeping-more-secrets-to-beat-copycats-in-china-e2d62868
Paid articlePaywall Elon Musk ignites the next stage: Are these the new stock market rockets?: SpaceX ahead of its IPO: The kiqreport highlights stocks that could benefit from the ...
deraktionaer.de/artikel/aktien/elon-musk-zuendet-die-naechste-stufe-sind-das-die-neuen-kursraketen-20401179.html
Barron's Mar 31
Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs: It’s no secret why major drug companies are looking to smaller biotechs for growth: many pharma ...
barrons.com/articles/biotechs-are-healthy-growth-bet-thanks-to-mergers-new-drugs-38e6cb8e
Paid articlePaywall Last chance for the mega anniversary deal: The next stock market rockets in sight
deraktionaer.de/artikel/aktien/letzte-chance-fuer-den-mega-jubilaeumsdeal-die-naechsten-kursraketen-im-visier-20396755.html
Biotechs are back in vogue - | hot comeback opportunity: Nasdaq Biotech Index reaches record high - | sector is booming, ideal entry point.
deraktionaer.de/artikel/deraktionaermagazin/biotechs-sind-wieder-en-vogue-heisse-comeback-chance-20396120.html
STAT Feb 11
Biotechs, wary of being tied to Big Pharma, form new industry group as hedge against Trump policies
statnews.com/2026/02/11/biotech-drug-pricing-trump-mbaa/
Paid articlePaywall The Professionals' Watchlist (Part 2): Are these the stock market rockets for 2026?
deraktionaer.de/artikel/aktien/die-wachtlist-der-profis-teil-2-sind-das-die-kursraketen-fuer-2026--20393649.html
Funding for Risky Biotechs Is Returning: Publicly traded drug developers sold more than $13 billion of shares in the fourth quarter, the most in more than four ...
wsj.com/tech/biotech/funding-for-risky-biotechs-is-returning-fc21ebe7
Paid articlePaywall Barron's Dec 08 25
Obesity Biotechs’ Gains Hit Shares of Eli Lilly, Novo Nordisk: Data from Structure Therapeutics and WAVE Life Sciences show that threats to Eli Lilly and Novo ...
barrons.com/articles/obesity-biotechs-structure-wave-lilly-novo-556ea734
Paid articlePaywall Biotech companies in takeover fever: Next bidding war: Pfizer outbids Novo Nordisk for Metsera; Lundbeck bids for Avadel, competing with Alkermes.
deraktionaer.de/artikel/pharma-biotech/biotechs-im-uebernahmefieber-naechster-bieterkampf-20390464.html
Micron is a huge success - | now the next stock market rockets await: 13F reports reveal top Wall Street investments. Next edition on November 28.
deraktionaer.de/artikel/aktien/micron-schlaegt-voll-ein-jetzt-warten-die-naechsten-kursraketen-20389973.html
Biotechs Turn to Digital Coins, Crypto to Boost Stock Prices: They’re supposed to be on the cutting edge of medicine. Yet some tiny biotech companies ...
bloomberg.com/news/articles/2025-08-25/biotechs-turn-to-digital-coins-crypto-to-boost-stock-prices
Paid articlePaywall Blueprint, Verona, CureVac & Co: Biotechs in takeover fever - | Seize the comeback opportunity now
deraktionaer.de/artikel/aktien/blueprint-verona-curevac-co-biotechs-im-uebernahme-fieber-jetzt-comeback-chance-nutzen-20383625.html
Pharmaceutical industry: China's biotech boom threatens German growth hopes: For a long time, China was only considered a manufacturer of copycat drugs ...
handelsblatt.com/unternehmen/industrie/pharmaindustrie-chinas-biotech-boom-bedroht-deutsche-wachstumshoffnung/100118102.html
Paid articlePaywall
Springworks Therapeutics: Merck with a multi-billion dollar pharmaceutical deal: The Darmstadt-based DAX-listed company is securing important supplies for its ...
faz.net/aktuell/wirtschaft/unternehmen/springworks-therapeutics-merck-mit-milliardenschweren-pharmadeal-110443496.html
Next